1-9 of 9
episode of care
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Medicare Patients Receiving Chimeric Antigen Receptor T-Cell Therapy for Non-Hodgkin Lymphoma: A First Real-World Look at Patient Characteristics, Healthcare Utilization and Costs

Karl M. Kilgore, PhD, Iman Mohammadi, PhD, Amy Schroeder, BPharm, Christie Teigland, PhD, Anna Purdum, PharmD,MS, Gunjan L. Shah, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 793.
https://doi.org/10.1182/blood-2019-124364
Published: 2019
Journal Articles

The Impact of Chronic Myeloid Leukemia Therapy Management on the Oncology Care Model

Elias J. Jabbour, MD, Martin F Mendiola, MD MPH, Melissa Lingohr-Smith, PhD, Brandy Menges, PhD, Jay Lin, PhD MBA, Dinara Makenbaeva, MD MBA
Journal: Blood
Blood (2018) 132 (Supplement 1): 2265.
https://doi.org/10.1182/blood-2018-99-112484
Published: 2018
Journal Articles

Economic Burden of Treatment Episodes in Acute Myeloid Leukemia (AML) Patients in the US: A Retrospective Analysis of a Commercial Payer Database

Bruno C Medeiros, MD, Bhavik J Pandya, PharmD, Chi-Chang Chen, PhD, Eric S. Groves, MD PhD, Cat N. Bui, PhD, Laura Elise Horvath, MD, Rolin L. Wade, RpH, MS
Journal: Blood
Blood (2017) 130 (Supplement 1): 4694.
https://doi.org/10.1182/blood.V130.Suppl_1.4694.4694
Published: 2017
Journal Articles

Real-World Occurrence of Symptoms and Toxicities and Associated Cost Implications in Acute Myeloid Leukemia (AML) Treatment Episodes: A Retrospective Database Analysis in the US

Bhavik J Pandya, PharmD, Bruno C Medeiros, MD, Chi-Chang Chen, PhD, Samuel Wilson, PhD, Eric S. Groves, MD PhD, Laura Elise Horvath, MD, Rolin L. Wade, RpH, MS
Journal: Blood
Blood (2017) 130 (Supplement 1): 2118.
https://doi.org/10.1182/blood.V130.Suppl_1.2118.2118
Published: 2017
Journal Articles

Differences In Treatment Patterns and Costs Among Diffuse Large B-Cell Lymphoma Patients Treated In The Clinic Vs. The Hospital Outpatient Setting

Carolina Reyes, PhD, Stacey Dacosta Byfield, Laura K. Becker, MS, Art Small, MD
Journal: Blood
Blood (2013) 122 (21): 1751.
https://doi.org/10.1182/blood.V122.21.1751.1751
Published: 2013
Journal Articles

Are There Differences in Patient Characteristics, Treatment Patterns and Costs by Treatment Setting?

Stacey Dacosta Byfield, Carolina Reyes, Ph.D., Laura K Becker, MS, Art Small, MD
Journal: Blood
Blood (2012) 120 (21): 4259.
https://doi.org/10.1182/blood.V120.21.4259.4259
Published: 2012
Journal Articles

Trajectory of Hemoglobin (Hb) in Patients Receiving Erythropoiesis-Stimulating Agents (ESAs) for Anemia Due to Concomitantly Administered Myelosuppressive Chemotherapy (CIA) (2006∼2008).

Jerrold Hill, PhD, Ze Cong, MS, Mphil, Gregory P. Hess, MD, MBA, MSc, Robert Nordyke, PhD
Journal: Blood
Blood (2009) 114 (22): 1399.
https://doi.org/10.1182/blood.V114.22.1399.1399
Published: 2009
Journal Articles

The Impact of Methodological Approach on Cost Findings in Comparison of Epoetin Alfa with Darbepoetin Alfa

Xue Song, Stacey R Long, William D Marder, Sean D Sullivan, Joel Kallich, PhD
Journal: Blood
Blood (2008) 112 (11): 1298.
https://doi.org/10.1182/blood.V112.11.1298.1298
Published: 2008
Journal Articles

Cost Estimates of Managing Grade III and IV Pleural Effusions, Pericardial Effusions, and Non-Variceal Gastrointestinal Hemorrhages in Cancer Patients.

Grant H. Skrepnek, PhD, Jeana L. Skora, PharmD
Journal: Blood
Blood (2006) 108 (11): 5510.
https://doi.org/10.1182/blood.V108.11.5510.5510
Published: 2006